(Oct 9): Peter Choo Chee Kong, the one-time IPO king of the local market, says the Singapore Exchange ought to take a leaf out of Bursa Malaysia’s book and set up a third board for fast-growing upstart companies in cutting-edge fields such as stem cell technology. Quite apart from the access to funding, a listing would greatly benefit such companies in terms of building their public profile.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply